Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
20 Nov, 2013, 09:05 ET
NEW YORK, November 20, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom
Today, Analysts' Corner announced new research reports highlighting Zoetis Inc. (NYSE: ZTS), Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), Edwards Lifesciences Corp. (NYSE: EW), Community Health Systems, Inc. (NYSE: CYH), and Air Methods Corp. (NASDAQ: AIRM). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Zoetis Inc. Research Report
On November 12, 2013, Zoetis Inc. (Zoetis) announced that the Company will participate in the 25th Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2013 at the New York Palace Hotel in New York City. The Company stated that Rick Passov, Executive Vice President and CFO of Zoetis, will speak on behalf of Zoetis and will respond to questions from analysts during his presentation, which is scheduled to take place at 11:30 a.m. ET on the aforesaid date. The Full Research Report on Zoetis Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Aegerion Pharmaceuticals, Inc. Research Report
On November 14, 2013, Aegerion Pharmaceuticals, Inc. (Aegerion) announced its participation in the Jefferies 2013 Global Healthcare Conference in London. The Company stated that its CFO Mark Fitzpatrick is scheduled to make a presentation on Thursday, November 21, 2013 at 10:00 a.m. GMT or 5:00 a.m. EST. Aegerion informed that the Company's CEO, Marc Beer will also make a presentation in the Deutsche Bank BioFEST Conference in Boston, on December 3, 2013 at 1:05 p.m. EST. The Company added that live webcast of the presentations can be accessed through "Investors" section of Aegerion's website. The Full Research Report on Aegerion Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Edwards Lifesciences Corp. Research Report
On November 14, 2013, Edwards Lifesciences Corp. (Edwards) reported that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a €5 million bond by Medtronic. The Company stated that this action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October 2013 indicating concerns about the validity of the Edwards Spenser patent. The Full Research Report on Edwards Lifesciences Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Community Health Systems, Inc. Research Report
On November 13, 2013, Community Health Systems, Inc. (CHS) issued a comment on the statement by Health Management Associates (HMA) regarding CHS's pending acquisition of HMA. According to the Company, HMA in its statement announced that its Board of Directors has completed its review of the merger agreement between the two parties and unanimously recommends that HMA stockholders vote "FOR" the adoption of the agreement. CHS stated that it expressed its appreciation to HMA's Board of Directors for its comprehensive evaluation and full support of the transaction. Commenting on HMA's announcement, Wayne T. Smith, Chairman, President and CEO of CHS, said, "We are pleased that HMA's Board of Directors unanimously supports the merger agreement and appreciate their thoughtful review of this important opportunity. While our industry faces a challenging operating environment overall, we continue to believe in the long-term strategic and financial benefits to be gained from the combination of our organizations. We look forward to the HMA stockholder vote on the merger agreement and to working closely with HMA to finalize this transaction. As we broaden our network of hospitals, continue to deliver quality care in communities across the nation, and realize the meaningful synergies available as a result of this merger, we will be well positioned for success." The Full Research Report on Community Health Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Air Methods Corp. Research Report
On November 12, 2013, Air Methods Corp. (Air Methods) announced that its United Rotorcraft Division completed and delivered the first of four medically-equipped Bell 407GX helicopters to CareFlite, a non-profit corporation providing medical transport across North Texas. The Company added that the other three medically-equipped Bell 407GXs are expected to be completed and delivered to CareFlite by the end of 2013. Mike Slattery, United Rotorcraft President, said, "United Rotorcraft is honored to have earned CareFlite's trust in completing the medical interior for their four new Bell 407GXs. We were able to leverage our unique internal Federal Aviation Administration Organization Designation Authorization status to quickly obtain Supplemental Type Certification approval for the medical interior and avionics suite and complete the work on this first unit in only 90 days." The Full Research Report on Air Methods Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
Share this article